Literature DB >> 34934519

Feasibility of Booster Vaccination in High-Risk Populations for Controlling Coronavirus Variants - China, 2021.

Kangguo Li1, Zeyu Zhao1,2, Hongjie Wei1, Jia Rui1, Jiefeng Huang1, Xiaohao Guo1, Yichao Guo1, Shiting Yang1, Guzainuer Abudurusuli1, Li Luo1, Xingchun Liu1, Yao Wang1, Jingwen Xu1, Yuanzhao Zhu1, Meng Yang1, Tianlong Yang1, Weikang Liu1, Bin Deng1, Chan Liu1, Zhuoyang Li1, Peihua Li1, Shanshan Yu1, Zimei Yang1, Yanhua Su1, Benhua Zhao1, Yan Niu3, Tianmu Chen1.   

Abstract

INTRODUCTION: Vaccination booster shots are completely necessary for controlling breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China. The study aims to estimate effectiveness of booster vaccines for high-risk populations (HRPs).
METHODS: A vaccinated Susceptible-Exposed-Symptomatic-Asymptomatic-Recovered/Removed (SEIAR) model was developed to simulate scenarios of effective reproduction number (R eff ) from 4 to 6. Total number of infectious and asymptomatic cases were used to evaluated vaccination effectiveness.
RESULTS: Our model showed that we could not prevent outbreaks when covering 80% of HRPs with booster unless R eff =4.0 or the booster vaccine had efficacy against infectivity and susceptibility of more than 90%. The results were consistent when the outcome index was confirmed cases or asymptomatic cases.
CONCLUSIONS: An ideal coronavirus disease 2019 (COVID-19) booster vaccination strategy for HRPs would be expected to reach the initial goal to control the transmission of the Delta variant in China. Accordingly, the recommendation for the COVID-19 booster vaccine should be implemented in HRPs who are already vaccinated and could prevent transmission to other groups. Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021.

Entities:  

Keywords:  China; booster; high-risk population; vaccinations

Year:  2021        PMID: 34934519      PMCID: PMC8671839          DOI: 10.46234/ccdcw2021.259

Source DB:  PubMed          Journal:  China CDC Wkly        ISSN: 2096-7071


  6 in total

1.  Mix-and-match COVID vaccines trigger potent immune response.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

2.  Effectiveness of Interventions to Control Transmission of Reemergent Cases of COVID-19 - Jilin Province, China, 2020.

Authors:  Qinglong Zhao; Meng Yang; Yao Wang; Laishun Yao; Jianguo Qiao; Zhiyong Cheng; Hanyin Liu; Xingchun Liu; Yuanzhao Zhu; Zeyu Zhao; Jia Rui; Tianmu Chen
Journal:  China CDC Wkly       Date:  2020-08-21

3.  The transmissibility and control of pandemic influenza A (H1N1) virus.

Authors:  Yang Yang; Jonathan D Sugimoto; M Elizabeth Halloran; Nicole E Basta; Dennis L Chao; Laura Matrajt; Gail Potter; Eben Kenah; Ira M Longini
Journal:  Science       Date:  2009-09-10       Impact factor: 47.728

4.  A mathematical model for simulating the phase-based transmissibility of a novel coronavirus.

Authors:  Tian-Mu Chen; Jia Rui; Qiu-Peng Wang; Ze-Yu Zhao; Jing-An Cui; Ling Yin
Journal:  Infect Dis Poverty       Date:  2020-02-28       Impact factor: 4.520

5.  A five-compartment model of age-specific transmissibility of SARS-CoV-2.

Authors:  Ze-Yu Zhao; Yuan-Zhao Zhu; Jing-Wen Xu; Shi-Xiong Hu; Qing-Qing Hu; Zhao Lei; Jia Rui; Xing-Chun Liu; Yao Wang; Meng Yang; Li Luo; Shan-Shan Yu; Jia Li; Ruo-Yun Liu; Fang Xie; Ying-Ying Su; Yi-Chen Chiang; Ben-Hua Zhao; Jing-An Cui; Ling Yin; Yan-Hua Su; Qing-Long Zhao; Li-Dong Gao; Tian-Mu Chen
Journal:  Infect Dis Poverty       Date:  2020-08-26       Impact factor: 4.520

  6 in total
  1 in total

1.  Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China.

Authors:  Weikang Liu; Zhinan Guo; Buasiyamu Abudunaibi; Xue Ouyang; Demeng Wang; Tianlong Yang; Bin Deng; Jiefeng Huang; Benhua Zhao; Yanhua Su; Chenghao Su; Tianmu Chen
Journal:  Front Public Health       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.